Tenax Therapeutics to Host Virtual R&D Webinar with Scientific Experts Highlighting HELP Study Results

Author's Avatar
Nov 06, 2020
Article's Main Image

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that it will host a virtual R&D webinar for analysts and investors on Wednesday, November 18, 2020 at 4:30 p.m. EST.